Skip to content

Study of a Candidate Gene Involved in Goldenhar Syndrome.

Identification and Investigation of a Gene Involved in Monogenic Forms of Goldenhar Syndrome.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04056858
Acronym
GOLDGEN
Enrollment
248
Registered
2019-08-14
Start date
2012-09-29
Completion date
2014-01-08
Last updated
2019-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Goldenhar Syndrome, Oculoauriculovertebral Dysplasia

Keywords

array-CGH, exome sequencing

Brief summary

The aim of this study is to identify of the first gene involved in the Goldenhar syndrome in a cohort of 120 affected patients.

Detailed description

Goldenhar syndrome belongs to the heterogeneous spectrum of oculoauriculovertebral dysplasia. Several chromosomal abnormalities have been described associated with this spectrum, and furthermore mutations in different genes of development cause abnormalities of the jaw or facial asymmetries in human or mouse. To date, no gene has been identified as formally involved in the genesis of the OAVS, despite evidence of familial cases, mostly with autosomal dominant inheritance. The aim of this study is to identify of the first gene involved in the Goldenhar syndrome in a cohort of 120 affected patients.

Interventions

None listed

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Spectrum of oculoauriculovertebral dysplasia minimal features include unilateral microtia and hemifacial microsomia

Exclusion criteria

* Absence of minimal spectrum of oculoauriculovertebral dysplasia features, molecular anomaly identified, other diagnosis

Design outcomes

Primary

MeasureTime frameDescription
presence of sequence variationAt the screeningIdentification of the first gene involved in Goldenhar syndrome

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026